Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Who wins, who loses with biogenerics
Who wins, who loses with biogenerics
Who wins, who loses with biogenerics
Submitted by
admin
on September 2, 2009 - 9:41am
Source:
Marketwatch
News Tags:
biogenerics
Neupogen
Amgen
Betaseron
Bayer
Humulin
Eli Lilly
Novolin
Novo Nordisk
Pulmozyme
Roche
Intron A
Infergen
Three Rivers Pharmaceuticals
Headline:
Who wins, who loses with biogenerics
Do Not Allow Advertisers to Use My Personal information
